Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management
 Wednesday, October 16, 2024
 11:00am EDT